Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted January 4, 2007
Sellers of Popular Weight Loss Supplements Pay $25 Million Over FTC Allegations of Deceptive Advertising
On January 4, 2007, the Federal Trade Commission (FTC) announced that it had filed complaints in four separate cases alleging that weight-loss and weight-control claims were not supported by competent and reliable scientific evidence. Marketers of the four products –Xenadrine EFX, CortiSlim, TrimSpa, and One-A-Day WeightSmart – have settled with the FTC, surrendered cash and other assets worth at least $25 million, and agreed to limit their future advertising claims.